Tel Aviv - Delayed Quote ILA
Enlivex Therapeutics Ltd. (ENLV.TA)
337.50
+6.90
+(2.09%)
At close: 5:24:34 PM GMT+3
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
36,831
67,642
95,146
40,358
Total Liabilities Net Minority Interest
6,747
10,801
10,107
4,871
Total Equity Gross Minority Interest
30,084
56,841
85,039
35,487
Total Capitalization
30,084
56,841
85,039
35,487
Common Stock Equity
30,084
56,841
85,039
35,487
Capital Lease Obligations
1,032
4,847
6,006
203
Net Tangible Assets
30,084
56,841
85,039
35,487
Working Capital
27,703
45,723
81,724
33,749
Invested Capital
30,084
56,841
85,039
35,487
Tangible Book Value
30,084
56,841
85,039
35,487
Total Debt
1,032
4,847
6,006
203
Share Issued
18,598.56
18,421.85
18,331.51
14,587.93
Ordinary Shares Number
18,598.56
18,421.85
18,331.51
14,587.93
12/31/2020 - 7/22/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LCTX.TA Lineage Cell Therapeutics, Inc.
169.10
+6.62%
KLDO Kaleido Biosciences, Inc.
0.0050
0.00%
BLRX.TA BioLineRx Ltd.
1.8000
+5.88%
EVGN.TA Evogene Ltd.
389.00
-7.49%
SCNI Scinai Immunotherapeutics Ltd.
2.2229
-10.73%
PYPD PolyPid Ltd.
2.6850
-2.36%
BCLI Brainstorm Cell Therapeutics Inc.
0.8800
+1.25%
BCDA BioCardia, Inc.
1.8300
-1.61%
PPBT Purple Biotech Ltd
2.8200
+4.64%
CELU Celularity Inc.
1.7000
+5.59%